Rapamycin augments Akt activation in in vitro and in vivo models of cardiac hypertrophy

被引：0
|
作者：
Johnston, Rebecca K. [1 ]
Van Laer, An O. [1 ]
Baicu, Catalin F. [1 ]
Zile, Michael R. [1 ]
Kuppuswamy, Dhandapani [1 ]
机构：
[1] Med Univ S Carolina, Charleston, SC 29425 USA
来源：
JOURNAL OF CARDIAC FAILURE | 2008年 / 14卷 / 06期
关键词：
D O I：
10.1016/j.cardfail.2008.06.298
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
138
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [21] Fas receptor signaling is not involved in cardiac myocyte apoptosis, but mediates cardiac hypertrophy in vitro and in vivo
    Dimmeler, S
    Ruetten, H
    Jung, F
    Ihling, C
    Badorff, C
    Zeiher, AM
    CIRCULATION, 2000, 102 (18) : 213 - 213
  • [22] Dyxin/Lmcd1 Mediates Cardiac Hypertrophy Both In Vitro And In Vivo
    Frank, Derk
    Frauen, Robert
    Hanselmann, Christiana
    Kuhn, Christian
    Will, Rainer
    Katus, Hugo A.
    Frey, Norbert
    CIRCULATION, 2008, 118 (18) : S393 - S393
  • [23] Elongator Protein 2 Plays an Important Role in Cardiac Hypertrophy In Vitro and In Vivo
    Okamoto, Ryuji
    Goto, Itaru
    Kobayashi, Issei
    Shimojo, Naoshi
    Dohi, Kaoru
    Nakamura, Mashio
    Ito, Masaaki
    JOURNAL OF CARDIAC FAILURE, 2014, 20 (10) : S188 - S188
  • [24] Ivermectin Augments the In Vitro and In Vivo Efficacy of Cisplatin in Epithelial Ovarian Cancer by Suppressing Akt/mTOR Signaling
    Zhang, Xiaohong
    Qin, Tingting
    Zhu, Zhengyan
    Hong, Fan
    Xu, Yang
    Zhang, Xiongjie
    Xu, Xiaohong
    Ma, Aiping
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2020, 359 (02): : 123 - 129
  • [25] Isoliquiritigenin attenuates pathological cardiac hypertrophy via regulating AMPKα in vivo and in vitro
    Gao, Meiling
    Cai, Qiang
    Si, Haichao
    Shi, Si
    Wei, Huixia
    Lv, Miaomiao
    Wang, Xiaofan
    Dong, Tieli
    JOURNAL OF MOLECULAR HISTOLOGY, 2022, 53 (04) : 679 - 689
  • [26] Attenuation of cardiac hypertrophy by inhibiting both mTOR and NFκB activation in vivo
    Ha, TZ
    Li, YH
    Gao, X
    McMullen, JR
    Shioi, T
    Izumo, S
    Kelley, JL
    Zhao, AQ
    Haddad, GE
    Williams, DL
    Browder, IW
    Kao, RL
    Li, CF
    FREE RADICAL BIOLOGY AND MEDICINE, 2005, 39 (12) : 1570 - 1580
  • [27] Isoliquiritigenin attenuates pathological cardiac hypertrophy via regulating AMPKα in vivo and in vitro
    Meiling Gao
    Qiang Cai
    Haichao Si
    Si Shi
    Huixia Wei
    Miaomiao Lv
    Xiaofan Wang
    Tieli Dong
    Journal of Molecular Histology, 2022, 53 : 679 - 689
  • [28] SUMO2 Induces Cardiac Hypertrophy in Vivo and in Vitro, Independent of Sumoylation
    Bernt, Alexander
    Rangrez, Ashraf Y.
    Eden, Matthias
    Rohr, Claudia
    Katz, Sylvia
    Jungmann, Andreas
    Williams, Tatjana
    Ritter, Oliver
    Muller, Oliver J.
    Katus, Hugo A.
    Frank, Derk
    Frey, Norbert
    CIRCULATION, 2016, 134
  • [29] SUMO2 Induces Cardiac Hypertrophy in Vivo and in Vitro, Independent of Sumoylation
    Bernt, Alexander
    Rangrez, Ashraf Y.
    Eden, Matthias
    Rohr, Claudia
    Katz, Sylvia
    Jungmann, Andreas
    Williams, Tatjana
    Ritter, Oliver
    Mueller, Oliver J.
    Katus, Hugo A.
    Frank, Derk
    Frey, Norbert
    CIRCULATION, 2016, 134
  • [30] Sirnvastatin prevents cardiac hypertrophy in vitro and in vivo via JAK/STAT pathway
    Liu, Juan
    Shen, Qin
    Wu, Yang
    LIFE SCIENCES, 2008, 82 (19-20) : 991 - 996
12345